Skip to content

Skip to Main Content | Accessibility features|Sitemap

A^-
A
A⁺

A
A

Directorate Of Food And Drugs Administration

Search for:

Home
Media
RTI
Tenders
FAQ’S
Vacancies
Links
Alerts
Feedback Form

A^-
A
A⁺

A
A

Directorate Of Food And Drugs Administration

Home
NEWS IN FOCUS
Notification under Section 26A restricting the sale of Oxytocin drug

Notification under Section 26A restricting the sale of Oxytocin drug

By Editor Auditor / June 26, 2024

Notification under Section 26A restricting the sale of Oxytocin drug

Post navigation

← Previous Post

Home
Media
RTI
Tenders
FAQ’S
Vacancies
Links
Alerts
Feedback Form

Search for:

FDA Directory

Blood Banks
Blood Storage Centers
Manufacturers
Officers Directory
Retailers Directory
Schedule X License Holder

Policies

-Disclaimer
-Hyperlinking Policy
-Privacy Policy
-Terms and Conditions
-Sitemap
-FAQ
-Contact Us

Application Forms

Food Forms
Drug Forms

Fees Structure

Fees Structures

News & Events

FDA Events & Happenings

Legislation

Acts & Rules
Cosmetic Forms
Drug Price Control Order
Forms

Visitor Counter

15570

Last Updated

June 26, 2024

Copyright © 2024 Directorate Of Food And Drugs Administration | Design, Developed And Maintained by Demerg Systems India

Scroll to Top